Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Donev_Sopharma_EN_Sell_20122023.pdf Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 247 / 2023
Date of issue: 2023-12-21
Short name of the issuer
SOPHARMA AD
Subject
Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023
Annexes
File Description
Donev_Sopharma_EN_Sell_20122023.pdf
Donev_Sopharma_EN_Sell_20122023.pdf		 Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 20 December 2023

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-12-21 Ognian Donev Executive director
20231221_152153_1778261731_Donev_Sopharma_EN_Sell_20122023.pdf

Pobierz